Category: Monteris Medical
Investment in medical device companies hit a 6-year high in Minnesota in 2014, according to data from LifeScience Alley's annual report on investing in the North Star State.
Investment in Minnesota's thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley's annual report.
Here's a look at some of the top legal news stories for medical device companies this week: Vascular Dynamics raises $10m; Spiracur raises $16m from GE Capital; Biolase lands $35m private placement; Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser
Monteris Medical says it's drummed up a $30 million Series B round for its NeuroBlate laser robotic surgery platform.
Monteris Medical said a pair of new backers joined a $30 million Series B round it plans to use to expand the commercial footprint of its NeuroBlate robotic brain tumor laser.
OrthoSensor picks up another $13 million, taking its Series B total to $48 million for its Verasense knee replacement device following CE Mark approval in the European Union.
OrthoSensor said it added $13 million to its Series B round, taking the total for the round to $48 million as it looks to capitalize on regulatory nods for its Verasense knee replacement device in the U.S. and Europe.
Monteris Mecical scores regulatory wins in the U.S. and in Canada, also touting positive clinical trial results for the NeuroBlate MRI-guided brain tumor treatment system.
Monteris Medical won a regulatory nod in the U.S. and in Canada for its NeuroBlate MRI-guided tumor ablation device, the company said.
Monteris Medical raises $7.8 million, saying it plans to boost marketing of its NeuroBlate neurosurgical ablation device.
Monteris Medical closed a $7.8 million funding round it plans to use to commercialize its NeuroBlate neurosurgical ablation device for treating brain tumors.
The round, led by Business Development Bank of Canada, also included the SWMF Life Science Fund and several independent parties. Monteris drummed up $9 million last May, according to a press release.
MFS Investment Management, which invented the mutual fund, adds 7 million shares to its stake in St. Jude Medical, taking its share to 10% of the medical device maker; also, Smith & Nephew's Bioventus ortho-biologics JV fledges, Kalypto deal closes; Kerberos Proximal Solutions puts Rinspiration on the auction block; NeuroLogica helps develop 1st mobile stroke ambulance; Xtend Medical gets into the entertainment game; plus, a Funding Roundup and analysts' ups and downs.
St. Jude Medical's (NYSE:STJ) largest investor boosted its stake by more than 30%, to some 27.2 million shares, or about 10% of the medical device maker.
, Bioventus LLC
, Edwards Lifesciences
, Kalypto Medical
, Kerberos Proximal Solutions
, Medical Care Technologies
, Meytec GmbH
, Monteris Medical
, NeuroLogica Corp.
, Orthosensor Inc.
, Smith & Nephew
, St. Jude Medical
, Stereotaxis Inc.
, XTend Medical